Jnj 67571244 is a drug used to treat Leukemia, Myeloid, Acute and Myelodysplastic Syndromes. Jnj 67571244 is being actively studied in 1 study; no studies for this drug have been completed so far.
|Top Sponsors||Top Sites||Top Investigators|
|Janssen Research & Development, LLC||Barbara Ann Karmanos Cancer Institute|
|Beth Israel Deaconess Medical Center|
|Clinica Univ. de Navarra|